Your browser doesn't support javascript.
loading
SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into Practice.
Ali, Amar; Bain, Steve; Hicks, Debbie; Newland Jones, Phillip; Patel, Dipesh C; Evans, Marc; Fernando, Kevin; James, June; Milne, Nicola; Viljoen, Adie; Wilding, John.
Afiliação
  • Ali A; Oakenhurst Medical Practice, Blackburn, UK.
  • Bain S; Diabetes Research Unit Cymru, Swansea University, Swansea, UK.
  • Hicks D; Medicus Health Partners, Enfield, UK.
  • Newland Jones P; University Hospitals Southampton NHS Foundation Trust, Southampton, UK.
  • Patel DC; Department of Diabetes and Endocrinology, Division of Medicine, University College London, London, UK.
  • Evans M; Department of Diabetes, University Hospital Llandough, Llandough, UK.
  • Fernando K; North Berwick Health Centre, North Berwick, UK.
  • James J; University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Milne N; CODES (Community Diabetes Education and Support), Manchester University NHS Foundation Trust, Manchester, UK.
  • Viljoen A; Department of Metabolic Medicine/Chemical Pathology, Lister Hospital, Stevenage, UK.
  • Wilding J; Obesity and Endocrinology Research, University of Liverpool, Liverpool, UK. J.P.H.Wilding@liverpool.ac.uk.
Diabetes Ther ; 10(5): 1595-1622, 2019 Oct.
Article em En | MEDLINE | ID: mdl-31290126
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article